Shah K - Search Results

1

Exploration of the Reasons Why Health State Valuation Differs for Children Compared With Adults: A Mixed Methods Approach.

Dewilde S, Janssen MF, Lloyd AJ, Shah K. Dewilde S, et al. Among authors: shah k. Value Health. 2022 Jul;25(7):1185-1195. doi: 10.1016/j.jval.2021.11.1377. Epub 2022 Feb 28. Value Health. 2022. PMID: 35232661 Free article.

2

An Empirical Study of Two Alternative Comparators for Use in Time Trade-Off Studies.

Shah K, Mulhern B, Longworth L, Janssen MF. Shah K, et al. Value Health. 2016 Jan;19(1):53-9. doi: 10.1016/j.jval.2015.10.012. Epub 2015 Dec 2. Value Health. 2016. PMID: 26797236 Free article.

3

Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods: Does Dimension Order Impact on Health State Values?

Mulhern B, Shah K, Janssen MF, Longworth L, Ibbotson R. Mulhern B, et al. Among authors: shah k. Value Health. 2016 Mar-Apr;19(2):210-7. doi: 10.1016/j.jval.2015.11.005. Epub 2016 Jan 8. Value Health. 2016. PMID: 27021755 Free article.

4

EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes.

Oppe M, Rand-Hendriksen K, Shah K, Ramos-Goñi JM, Luo N. Oppe M, et al. Among authors: shah k. Pharmacoeconomics. 2016 Oct;34(10):993-1004. doi: 10.1007/s40273-016-0404-1. Pharmacoeconomics. 2016. PMID: 27084198 Free PMC article.

5

Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets.

Mulhern B, Feng Y, Shah K, Janssen MF, Herdman M, van Hout B, Devlin N. Mulhern B, et al. Among authors: shah k. Pharmacoeconomics. 2018 Jun;36(6):699-713. doi: 10.1007/s40273-018-0628-3. Pharmacoeconomics. 2018. PMID: 29476363 Free PMC article.

6

Correction to: Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets.

Mulhern B, Feng Y, Shah K, Janssen MF, Herdman M, van Hout B, Devlin N. Mulhern B, et al. Among authors: shah k. Pharmacoeconomics. 2018 Jun;36(6):727. doi: 10.1007/s40273-018-0648-z. Pharmacoeconomics. 2018. PMID: 29679315 Free PMC article.

7

Evaluation of Split Version and Feedback Module on the Improvement of Time Trade-Off Data.

Wong ELY, Shah K, Cheung AWL, Wong AYK, Visser M, Stolk E. Wong ELY, et al. Among authors: shah k. Value Health. 2018 Jun;21(6):732-741. doi: 10.1016/j.jval.2017.10.013. Value Health. 2018. PMID: 29909879 Free article.

8

Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L.

Hobbins A, Barry L, Kelleher D, Shah K, Devlin N, Goni JMR, O'Neill C. Hobbins A, et al. Among authors: shah k. Pharmacoeconomics. 2018 Nov;36(11):1345-1353. doi: 10.1007/s40273-018-0690-x. Pharmacoeconomics. 2018. PMID: 30051267 Free PMC article. Clinical Trial.

9

Euthanasia, religiosity and the valuation of health states: results from an Irish EQ5D5L valuation study and their implications for anchor values.

Barry L, Hobbins A, Kelleher D, Shah K, Devlin N, Goni JMR, O'Neill C. Barry L, et al. Among authors: shah k. Health Qual Life Outcomes. 2018 Jul 31;16(1):152. doi: 10.1186/s12955-018-0985-9. Health Qual Life Outcomes. 2018. PMID: 30064460 Free PMC article.

10

International Valuation Protocol for the EQ-5D-Y-3L.

Ramos-Goñi JM, Oppe M, Stolk E, Shah K, Kreimeier S, Rivero-Arias O, Devlin N. Ramos-Goñi JM, et al. Among authors: shah k. Pharmacoeconomics. 2020 Jul;38(7):653-663. doi: 10.1007/s40273-020-00909-3. Pharmacoeconomics. 2020. PMID: 32297224

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,389 results

Search Page